Binding members for human cytomegalovirus

US9346874B2 · kind B2 · utility

Assignee

• 4-Antibody AG · CH

Inventors

• Ulf Grawunder · Basel, CH
• Michael Mach · Erlangen, DE
• Luis Martin-Parras · Jena, DE
• Sonja Potzsch · Hersbruck, DE
• Nadja Spindler · Frankfurt am Main, DE
• Heinrich Sticht · Fürth, DE
• Anna-Katharina Wiegers · Nuremberg, DE
• Thomas Winkler · Erlangen, DE

Key dates

• Filing date: Jun 22, 2012
• Grant date: May 24, 2016
• Expiry date: Nov 13, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to binding members, especially antibody molecules, which may neutralize the biological effects of human cytomegalovirus (hCMV). The binding members may be useful for the treatment and prophylaxis of hCMV infection.